SmartTRAK discusses key products and compelling clinical evidence that may impact the Bone Replacement Market in 2025 and beyond.

SmartTRAK looks at what’s on the horizon in 2025 and beyond and highlights the innovation and product advances that could shake up the US Market for Bone Replacement, which is projected to reach a 5-year CAGR of +3.8% by 2028. In this article, SmartTRAK details the recent growth factors/peptides bone grafts that received the FDA’s Breakthrough Device Designation (BDD) and significant milestones in product development in 2024. It also discusses new clinical evidence challenging the belief that autologous bone is the most efficacious graft material.

Curious which companies and products are making waves? This downloadable market outlook article covers, among others:

• Cerapedics' investigational P-15 Peptide Enhanced Bone Graft
• Medtronic’s Infuse bone graft
• Theradaptive's OsteoAdapt SP bone graft
• Bone Biologics' NB1 bone graft
• Locate Bio's LDGraft bone graft 
• Renovos' Renovite BMP-2 bone graft 
• CBBio's NOVOSIS Putty
• Amphix Bio's  drug-device combination product for bone regeneration
• Kuros Biosciences' MagnetOs Granules bone graft

With new growth factor/peptides bone grafts progressing with their timelines to the market and clinical data demonstrating superiority over autograft, the Bone Replacement market is primed to grow in 2025 and the coming years.

Click the button below to download and read the complete "Clinical Evidence Poised to Redefine the Bone Replacement Market in 2025 and Beyond" Market Outlook article by SmartTRAK Erin Dorgan, Sr Analyst.

New spine technologies "pushed the envelope" at MNVC

The Musculoskeletal New Ventures Conference (MNVC) is an annual meeting where early and late-stage companies present their ideas. This meeting occurred in Memphis, Tennessee, from October 28 - 30, with a broad mix of attendees, including surgeons, venture capitalists, the medical device industry and researchers. Forty companies presented this year, a record number for this meeting, focused exclusively on the musculoskeletal industry. In this article, SmartTRAK highlights six companies with new technologies to "push the envelope" in the US Spinal Hardware Market, which SmartTRAK estimates is growing at a 5-year CAGR of +4.7%.

This downloadable article provides an in-depth look at the following six companies' innovative new technologies:

New products and clinical data continue to grow the spinal hardware and bone replacement markets.

The North American Spine Society (NASS) was buzzing with new technologies at its 39th annual meeting in Chicago, September 25-28. Over 4,000 medical registrants and industry personnel attended this year’s meeting. This is the largest spine-focused meeting in the US, and it supports the spinal hardware and bone replacement markets. SmartTRAK estimates the spinal hardware market is poised to post a 5-yr CAGR of +4.7%, and the bone replacement market in spine is expected to reach a 5-year CAGR of +3.5%.

In this market perspective article, SmartTRAK highlights ...

• Spine Hardware Refreshed-The Latest Product Innovations
  
  • Pedicle Screws
  • Disc Prep
• Bone Replacement Market - New Products for DBM
  
  • The Data Race Continues
  • Product Innovations
• A Strong Showing from Korean Manufacturers
  • New this year at NASS was the Korean SpineTech Pavilion, sponsored by the Korean Ministry of Health and Welfare and the Korean Health Industry Development Institute. This pavilion housed smaller companies at one booth to showcase ...

Click the button below to download and read the complete "NASS 2024 Annual Meeting Highlights" market perspective article by Erin Dorgan, SmartTRAK Senior Analyst, Spine.

SmartTRAK takes a look at trends impacting the MIS Spine market.

In this article, SmartTRAK highlights key presentations and the latest trends from SMISS 2024 affecting the Spine Market. This includes what challenges still exist for MIS transforaminal lumbar interbody fusion (TLIF) procedures, considerations for surgeons learning the prone transpsoas (PTP) approach, indication expansion opportunities for cervical disc replacement (CDR) and factors that could disrupt the market for spine surgeons. SmartTRAK estimates these trends will contribute to the US MIS market 5-year CAGR of +7.0% by 2028. 

The topics covered include:

• New Technologies Help Advance MIS TLIF Procedures
  • SmartTRAK estimates that MIS posterior procedures will reach 88K in 2028E, and over half of the interbody procedures are ... (read more)
• Lateral Lumbar Interbody Procedures Growing in Mid-Single Digits
  • One of the fastest growing segments of the MIS Spine Market is Lateral Lumbar Interbody Fusion, which SmartTRAK estimates is growing with a 5-year CAGR of ... (read more)
• Cervical Disc Replacement Indications Poised to Expand
  • SmartTRAK estimates that the CDR market is one of the fastest growth markets in Spine, with a projected 5-year revenue ... (read more)
• ‘Innovator’s Dilemma’ Could Disrupt the Spine Market for Surgeons
  
  • Concluding the meeting with his presidential address, Sheeraz Qureshi, MD, MBA, Co-Chief of Hospital of Special Surgery Spine and an Attending Orthopedic Surgeon at HSS, shared his vision of the future of the Spine Market with ... (read more)

Click the button below to download and read the complete "SMISS 2024 - MIS Spine Continues to Grow" perspective article by Erin Dorgan, SmartTRAK Sr Analyst, Spine and Orthobiologics.